Human pluripotent stem cells for modeling toxicity

Area of Science:

• Biotechnology
• Toxicology
• Stem Cell Research

Background:

• The increasing development of xenobiotics for various uses necessitates robust toxicity screening.
• Current animal and in vitro models for xenobiotic safety assessment are costly, animal-intensive, and often lack clinical translatability.
• High rates of xenobiotic-induced toxicity contribute to patient morbidity and mortality, highlighting limitations in existing safety screening methods.

Purpose of the Study:

• To review the advancements in using human pluripotent stem cells (hPSCs) for modeling xenobiotic metabolism and toxicity.
• To discuss the challenges associated with hPSC-based toxicity studies.
• To provide perspectives on the future applications of hPSCs in drug toxicology and safety pharmacology.

Main Methods:

• Review of current literature on xenobiotic toxicity screening models.
• Exploration of human pluripotent stem cell technologies for generating metabolically competent cells.
• Analysis of hPSC-derived cell types for in vitro disease modeling in toxicology.

Main Results:

• Human pluripotent stem cells provide a renewable source of metabolically competent cells for toxicity testing.
• hPSC-derived models offer potential for more accurate prediction of drug toxicity compared to traditional methods.
• These models can be utilized for in vitro disease modeling relevant to drug toxicology.

Conclusions:

• Human pluripotent stem cells represent a significant advancement in developing more predictive models for xenobiotic metabolism and toxicity.
• Overcoming current challenges will be crucial for the widespread adoption of hPSC-based toxicity screening.
• Future research directions include refining hPSC differentiation protocols and validating their predictive capacity in drug safety assessment.